down arrow

Kimia Bioscien.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE285U01025
  • NSEID:
  • BSEID: 530313
INR
39.62
0.37 (0.94%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 584

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

39.0241.00

52 Week

37.3358.39
Valuation
Technical
Day's Volume

CASH

584 (-54.21%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.38%

Held by 0 DIIs

Promoter

74.94%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With HIgh Debt (Debt-Equity Ratio at 11.22 times)- the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate 0% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
  • The company has been able to generate a Return on Capital Employed (avg) of 5.80% signifying low profitability per unit of total capital (equity and debt)
2

Stock is technically in a Bearish range

3

With ROCE of 16.6, it has a Expensive valuation with a 5.4 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 187 Cr (Micro Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

11.22

stock-summary
Return on Equity

278.70%

stock-summary
Price to Book

54.94

Revenue and Profits (1 Year):
Net Sales:
30 Cr
(Quarterly Results - Dec 2024)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-20.84%
0%
-20.84%
1 Year
-26.04%
0%
-26.04%
2 Years
7.43%
0%
7.43%
3 Years
-13.4%
0%
-13.4%
4 Years
-1.81%
0%
-1.81%
5 Years
87.33%
0%
87.33%

Kimia Bioscien. for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
1.32%
EBIT Growth (5y)
41.82%
EBIT to Interest (avg)
0.42
Debt to EBITDA (avg)
2.41
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.19
Tax Ratio
24.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.38%
ROCE (avg)
-0.42%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
33
Price to Book Value
54.94
EV to EBIT
17.32
EV to EBITDA
13.77
EV to Capital Employed
5.41
EV to Sales
2.02
PEG Ratio
0.11
Dividend Yield
NA
ROCE (Latest)
16.61%
ROE (Latest)
278.70%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 3 Schemes (0.38%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Sameer Goel (74.94%)

Highest Public shareholder

Anish Kumar Aggarwal (4.33%)

Individual Investors Holdings

22.94%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 6.81% vs 25.80% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 183.85% vs 11.81% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.10",
          "val2": "28.18",
          "chgp": "6.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.00",
          "val2": "3.37",
          "chgp": "48.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.01",
          "val2": "1.04",
          "chgp": "-2.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.57",
          "val2": "1.61",
          "chgp": "183.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.61%",
          "val2": "11.96%",
          "chgp": "4.65%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 4.44% vs -37.14% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 159.22% vs -2,007.41% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.58",
          "val2": "48.43",
          "chgp": "4.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.07",
          "val2": "-3.60",
          "chgp": "296.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.15",
          "val2": "2.40",
          "chgp": "-10.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.05",
          "val2": "-5.15",
          "chgp": "159.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.98%",
          "val2": "-7.43%",
          "chgp": "21.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 8.19% vs -29.55% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 207.32% vs -122.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "80.68",
          "val2": "74.57",
          "chgp": "8.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.07",
          "val2": "-4.65",
          "chgp": "359.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.16",
          "val2": "3.71",
          "chgp": "-14.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.62",
          "val2": "-7.10",
          "chgp": "207.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.96%",
          "val2": "-6.24%",
          "chgp": "21.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -18.39% vs 2.90% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 43.21% vs -152.70% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "104.88",
          "val2": "128.52",
          "chgp": "-18.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.48",
          "val2": "-4.97",
          "chgp": "90.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.05",
          "val2": "4.25",
          "chgp": "18.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.05",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-5.31",
          "val2": "-9.35",
          "chgp": "43.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.46%",
          "val2": "-3.87%",
          "chgp": "3.41%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
30.10
28.18
6.81%
Operating Profit (PBDIT) excl Other Income
5.00
3.37
48.37%
Interest
1.01
1.04
-2.88%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.57
1.61
183.85%
Operating Profit Margin (Excl OI)
16.61%
11.96%
4.65%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 6.81% vs 25.80% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 183.85% vs 11.81% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
50.58
48.43
4.44%
Operating Profit (PBDIT) excl Other Income
7.07
-3.60
296.39%
Interest
2.15
2.40
-10.42%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.05
-5.15
159.22%
Operating Profit Margin (Excl OI)
13.98%
-7.43%
21.41%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 4.44% vs -37.14% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 159.22% vs -2,007.41% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
80.68
74.57
8.19%
Operating Profit (PBDIT) excl Other Income
12.07
-4.65
359.57%
Interest
3.16
3.71
-14.82%
Exceptional Items
0.00
0.00
Standalone Net Profit
7.62
-7.10
207.32%
Operating Profit Margin (Excl OI)
14.96%
-6.24%
21.20%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 8.19% vs -29.55% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 207.32% vs -122.57% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
104.88
128.52
-18.39%
Operating Profit (PBDIT) excl Other Income
-0.48
-4.97
90.34%
Interest
5.05
4.25
18.82%
Exceptional Items
0.00
-1.05
100.00%
Standalone Net Profit
-5.31
-9.35
43.21%
Operating Profit Margin (Excl OI)
-0.46%
-3.87%
3.41%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -18.39% vs 2.90% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 43.21% vs -152.70% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Kimia Biosciences Ltd stock-summary
stock-summary
Kimia Biosciences Ltd
Micro Cap
Pharmaceuticals & Drugs
Kimia Bio-sciences Limited (Formerly known Laurel Organics Limited) was incorporated in September, 1993 led by the Promoters, A K Bansal, K S Varma, Atul Sharma, A P Godiyal, D K Gupta and R K Bansal. The Company has own manufacturing of Bulk Drugs-APIs at its plant located at Gurgaon, Haryana. The Company is engaged into the business of Pharamaceutical products. The company set up a bulk drug manufacturing unit at Gurgaon, Haryana, at a project cost of Rs 10.41 cr.
Company Coordinates stock-summary
Company Details
Bhondsi Village, Tehsil Sohna Gurgaon Haryana : 122102
stock-summary
Tel: 91-11-29535650
stock-summary
http://www.kimiabiosciences.com
stock-summary
laurelorganicslimited@gmail.com
Registrar Details
Beetal Financial & Computer Services (P) Ltd , Beetal House , 99 Mandangir, 3rd Floor, Behind Local Shopping Centre, Near Dada Harsukhdas Mandir, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."